Skip to main content
. 2015 Mar 27;10(3):e0123396. doi: 10.1371/journal.pone.0123396

Table 1. Baseline characteristics of subjects according to the distribution of DNA methylation in subtypes of tissues.

Variables Total Methylation status
p16 MLH1 MGMT ≥ 1 of genes
Normal Tumor Normal Tumor Normal Tumor Normal Tumor
Sex, n (%)
    Male 109 (50.5) 27 (25.7) 66 (60.6) 19 (17.4) 24 (22.0) 18 (16.5) 63 (57.8) 45 (41.3) 87 (79.8)
    Female 106 (49.5) 35 (33.0) 52 (49.1) 19 (17.9) 25 (23.6) 13 (12.3) 56 (52.8) 51 (48.1) 80 (75.5)
    P value a 0.294 0.101 0.924 0.871 0.439 0.495 0.339 0.513
Age at surgery
    Mean (SD) 64.3 (14.5) 62.7 (14.3) 63.2 (15.7) 66.2 (12.3) 67.4 (12.9) 61.5 (15.2) 63.9 (14.3) 63.3 (14.6) 64.0 (15.0)
    ≤ 65, n (%) 107 (49.8) 32 (29.9) 63 (58.9) 18 (16.8) 21 (19.6) 19 (17.8) 62 (57.9) 51 (47.7) 87 (81.3)
    > 65, n (%) 108 (50.2) 31 (28.7) 55 (50.9) 20 (18.5) 28 (25.9) 12 (11.1) 57 (52.8) 45 (41.7) 80 (74.1)
    P value a 0.882 0.274 0.858 0.330 0.179 0.494 0.412 0.252
Stage, n (%)
    I 29 (13.6) 10 (34.5) 12 (41.4) 3 (10.3) 6 (20.7) 2 (6.9) 12 (41.4) 12 (41.4) 19 (65.5)
    II 78 (36.4) 23 (30.4) 45 (57.0) 13 (16.5) 16 (20.3) 9 (11.4) 44 (55.7) 35 (44.3) 63 (79.7)
    III 71 (33.2) 20 (28.2) 39 (54.9) 17 (23.9) 18 (25.4) 11 (15.5) 44 (62.0) 33 (46.5) 58 (81.7)
    IV 36 (16.8) 9 (25.0) 22 (61.1) 5 (13.9) 9 (25.0) 9 (25.0) 19 (52.8) 16 (44.4) 27 (75.0)
    P value a 0.853 0.417 0.331 0.867 0.154 0.302 0.973 0.324
Recurrence, n (%)
    Absence 130 (60.7) 32 (24.6) 64 (49.2) 19 (14.6) 27 (20.8) 13 (10.0) 68 (52.3) 49 (37.7) 95 (73.1)
    Presence 84 (39.3) 30 (36.5) 54 (63.5) 19 (22.4) 22 (25.9) 18 (21.2) 51 (60.0) 47 (55.3) 72 (84.7)
    P value a 0.068 0.027 0.200 0.409 0.029 0.326 0.012 0.065
Mortality, n (%)
    Absence 172 (79.9) 50 (29.1) 97 (56.4) 32 (18.6) 41 (23.8) 24 (14.0) 98 (57.0) 79 (45.9) 137 (79.7)
    Presence 43 (20.1) 13 (30.2) 21 (48.8) 6 (14.0) 8 (18.6) 7 (16.3) 21 (48.8) 17 (39.5) 30 (69.8)
    P value a 0.854 0.236 0.655 0.546 0.808 0.392 0.496 0.218

a P value for between group comparison with regard to methylation status in normal and tumor tissues.